• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

向正常人类志愿者成功经皮给予治疗剂量的多肽。

Successful transdermal administration of therapeutic doses of a polypeptide to normal human volunteers.

作者信息

Meyer B R, Kreis W, Eschbach J, O'Mara V, Rosen S, Sibalis D

机构信息

Department of Medicine, North Shore University Hospital, Manhasset, NY 11030.

出版信息

Clin Pharmacol Ther. 1988 Dec;44(6):607-12. doi: 10.1038/clpt.1988.201.

DOI:10.1038/clpt.1988.201
PMID:3143511
Abstract

The human stratum corneum constitutes a relatively impermeable barrier to the transdermal absorption of most substances, including polypeptides and proteins. This double-blind, randomized, crossover study in 13 normal men evaluated whether a low level of electrical current could induce changes in cutaneous permeability sufficient to produce absorption of a polypeptide. We compared cutaneous absorption of 5 mg of leuprolide (a 9 amino acid luteinizing hormone releasing hormone analogue) in transdermal patches containing 0.2 mA electrical current (active) and in patches containing no electrical current (passive). Serum luteinizing hormone (LH) concentration was measured 12 times during an 8-hour period as a measure of drug effect. Similar baseline LH levels were seen in each group: active = 11.3 +/- 3.1 mIU/ml and passive = 13.7 +/- 4.7 mIU/ml (p not significant). Significant elevations of LH were seen in active compared with passive patches (p = 0.0084). As predicted, passive patches produced no elevation of LH concentration (LH = 11.8 +/- 7.1 mIU/ml at 4 hours). However, active patches produced elevations comparable to those achieved with subcutaneous administration of the drug (LH = 56.4 +/- 49.6 mIU/ml at 4 hours and p = 0.003 compared with passive). The patches were well tolerated without significant cutaneous toxicity. It is concluded that the use of low levels of electrical current can induce changes in the permeability of the stratum corneum. These changes are sufficient to promote the transdermal absorption of therapeutically relevant amounts of a polypeptide. This has major importance for our understanding of skin permeability and for the development of new techniques for drug administration.

摘要

人类角质层对包括多肽和蛋白质在内的大多数物质的经皮吸收构成了相对不可渗透的屏障。这项针对13名正常男性的双盲、随机、交叉研究评估了低水平电流是否能诱导皮肤通透性发生变化,足以使多肽被吸收。我们比较了含0.2 mA电流的透皮贴剂(活性组)和不含电流的透皮贴剂(被动组)中5 mg亮丙瑞林(一种9氨基酸促黄体生成激素释放激素类似物)的皮肤吸收情况。在8小时内测量血清促黄体生成激素(LH)浓度12次,作为药物效果的指标。每组的基线LH水平相似:活性组 = 11.3±3.1 mIU/ml,被动组 = 13.7±4.7 mIU/ml(p无统计学意义)。与被动组相比,活性组的LH显著升高(p = 0.0084)。正如预期的那样,被动组的贴剂未使LH浓度升高(4小时时LH = 11.8±7.1 mIU/ml)。然而,活性组的贴剂使LH升高,与皮下给药达到的升高水平相当(4小时时LH = 56.4±49.6 mIU/ml,与被动组相比p = 0.003)。这些贴剂耐受性良好,无明显皮肤毒性。结论是,使用低水平电流可诱导角质层通透性发生变化。这些变化足以促进治疗相关量多肽的经皮吸收。这对于我们理解皮肤通透性以及开发新的药物给药技术具有重要意义。

相似文献

1
Successful transdermal administration of therapeutic doses of a polypeptide to normal human volunteers.向正常人类志愿者成功经皮给予治疗剂量的多肽。
Clin Pharmacol Ther. 1988 Dec;44(6):607-12. doi: 10.1038/clpt.1988.201.
2
Transdermal versus subcutaneous leuprolide: a comparison of acute pharmacodynamic effect.透皮注射与皮下注射亮丙瑞林:急性药效学效应比较
Clin Pharmacol Ther. 1990 Oct;48(4):340-5. doi: 10.1038/clpt.1990.161.
3
Transdermal delivery of human insulin to albino rabbits using electrical current.利用电流将人胰岛素经皮递送至白化兔体内。
Am J Med Sci. 1989 May;297(5):321-5. doi: 10.1097/00000441-198905000-00009.
4
Iontophoresis of polypeptides: effect of ethanol pretreatment of human skin.
J Pharm Sci. 1990 Jul;79(7):588-91. doi: 10.1002/jps.2600790708.
5
Pharmacokinetics of new testosterone transdermal therapeutic systems in gonadotropin-releasing hormone antagonist-suppressed normal men.新型睾酮透皮治疗系统在促性腺激素释放激素拮抗剂抑制的正常男性中的药代动力学
Exp Clin Endocrinol Diabetes. 1999;107(1):63-9. doi: 10.1055/s-0029-1212075.
6
Pharmacokinetics, endocrine and antitumour effects of leuprolide depot (TAP-144-SR) in advanced prostatic cancer: a dose-response evaluation.醋酸亮丙瑞林缓释微球(TAP - 144 - SR)在晚期前列腺癌中的药代动力学、内分泌及抗肿瘤作用:剂量反应评估
Drugs Exp Clin Res. 1989;15(8):373-87.
7
Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.男性使用促黄体生成素释放激素激动剂类似物进行长期治疗期间的促性腺激素和类固醇分泌模式。
J Clin Endocrinol Metab. 1984 May;58(5):862-7. doi: 10.1210/jcem-58-5-862.
8
Differential suppression of testosterone and estradiol in hirsute women with the superactive gonadotropin-releasing hormone agonist leuprolide.使用促性腺激素释放激素激动剂亮丙瑞林对多毛女性睾酮和雌二醇的差异性抑制作用
J Clin Endocrinol Metab. 1988 Oct;67(4):651-5. doi: 10.1210/jcem-67-4-651.
9
Aromatization mediates testosterone's short-term feedback restraint of 24-hour endogenously driven and acute exogenous gonadotropin-releasing hormone-stimulated luteinizing hormone and follicle-stimulating hormone secretion in young men.芳香化作用介导了睾酮对年轻男性24小时内源性驱动及外源性促性腺激素释放激素急性刺激下的促黄体生成素和促卵泡激素分泌的短期反馈抑制。
J Clin Endocrinol Metab. 2001 Jun;86(6):2600-6. doi: 10.1210/jcem.86.6.7520.
10
Effect of a new LH-RH analogue (D-Ser(TBU)6-EA10-LH-RH) on gonadotrophin and gonadal steroid secretion in men.一种新型促黄体生成激素释放激素类似物(D-丝氨酸(叔丁基)6-EA10-促黄体生成激素释放激素)对男性促性腺激素和性腺类固醇分泌的影响。
Horm Res. 1976;7(1):1-10. doi: 10.1159/000178702.

引用本文的文献

1
Effects of alternating current frequency and permeation enhancers upon human epidermal membrane.交流电流频率和渗透促进剂对人体表皮膜的影响。
Int J Pharm. 2009 May 8;372(1-2):24-32. doi: 10.1016/j.ijpharm.2008.12.036. Epub 2009 Jan 4.
2
Percutaneous absorption and anti-inflammatory effect of a substance P receptor antagonist: spantide II.P物质受体拮抗剂(spantide II)的经皮吸收及抗炎作用
Pharm Res. 2004 Jan;21(1):108-13. doi: 10.1023/b:pham.0000012157.80716.73.
3
Clinical pharmacokinetics of depot leuprorelin.长效亮丙瑞林的临床药代动力学
Clin Pharmacokinet. 2002;41(7):485-504. doi: 10.2165/00003088-200241070-00003.
4
Transdermal iontophoresis. Pharmacokinetic considerations.
Clin Pharmacokinet. 1994 May;26(5):327-34. doi: 10.2165/00003088-199426050-00001.
5
Effect of electroporation on transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro.体外电穿孔对促黄体生成素释放激素(LHRH)经皮离子导入递送的影响。
Pharm Res. 1994 Dec;11(12):1809-14. doi: 10.1023/a:1018983804635.
6
DC electrical properties of frozen, excised human skin.
Pharm Res. 1990 Feb;7(2):134-43. doi: 10.1023/a:1015820600672.
7
Transport of peptide and protein drugs across biological membranes.肽类和蛋白质药物跨生物膜的转运
Eur J Drug Metab Pharmacokinet. 1990 Apr-Jun;15(2):83-93. doi: 10.1007/BF03190191.
8
Novel drug delivery systems. An overview of their impact on clinical pharmacokinetic studies.新型药物递送系统。其对临床药代动力学研究影响的概述。
Clin Pharmacokinet. 1991 Jan;20(1):1-14. doi: 10.2165/00003088-199120010-00001.
9
Percutaneous absorption enhancement of leuprolide.
Pharm Res. 1992 Dec;9(12):1575-9. doi: 10.1023/a:1015860324161.
10
Delivery of hormones: some new concepts.
Pharm Weekbl Sci. 1992 Aug 21;14(4A):253-7. doi: 10.1007/BF01962547.